NASDAQ: GLSI - Greenwich LifeSciences, Inc.

Lønnsomhet i seks måneder: +14.66%
Sektor: Healthcare

Kampanjeplan Greenwich LifeSciences, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0034
Число акций ао 0.01285 млрд
P/BV 16.09
EV/EBITDA 0.0018
Цена ао 20.32
ISIN US3968791083
Сайт https://greenwichlifesciences.com
Валюта usd
IPO date 2020-09-25
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Prisendring per dag: -2.27% (14.16)
Prisendring per uke: +6.86% (12.95)
Prisendring per måned: -7.31% (14.93)
Prisendring over 3 måneder: -10.89% (15.53)
Prisendring over seks måneder: +14.66% (12.07)
Prisendring per år: +64.65% (8.405)
Prisendring over 3 år: -62.43% (36.84)
Prisendring siden begynnelsen av året: +21.93% (11.35)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 21.32 1
P/E 0 0
EV/EBITDA -14.57 0
Total: 1.63

Effektivitet

Navn Betydning Karakter
ROA, % -127.12 0
ROE, % -132.71 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 174.24 10
Lønnsomhet EPS, % 141.81 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
Vanguard Group Inc 221682 1.73
Blackrock Inc. 57148 0.44
Ameriprise Financial, Inc. 53647 0.42
Geode Capital Management, LLC 46816 0.36
Renaissance Technologies, LLC 36600 0.28
Northern Trust Corporation 20983 0.16
683 Capital Management LLC 19604 0.15
Qube Research & Technologies Ltd 14714 0.11
JANE STREET GROUP, LLC 14005 0.11
State Street Corporation 13002 0.1

ETF Dele, % Lønnsomhet for året, % Utbytte, %
ProShares Hedge Replication ETF 0.0005 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.02306 34.327031588619 1.54048
iShares Russell 2000 Growth ETF 0.00627 38.042556988 0.6026
ProShares UltraPro Russell2000 0.00192 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 37.361289927043 0.60264
Vanguard Russell 2000 ETF 0 32.773459189339 1.48801



Veileder Stillingstittel Betaling Fødselsår
Mr. Snehal S. Patel CEO, CFO & Director 1.09M 1964 (60 år)
Mr. Eric Rothe Founder & Independent Director 65.64k 1976 (48 år)
Dr. Frank Joseph Daugherty M.D. Chief Medical Officer & Director N/A 1951 (73 år)
Dr. Jaye L. Thompson Ph.D. Vice President Clinical & Regulatory Affairs N/A 1966 (58 år)
Dr. Christine T. Fischette Ph.D. VP of Business Development N/A 1951 (73 år)

Adresse: United States, Stafford. TX, Building 14 - åpne i Google maps, åpne Yandex-kart
Nettsted: https://greenwichlifesciences.com